Near-Patient Molecular Solutions Global Market Report 2025

Description

Near-patient molecular solutions are diagnostic tests that use molecular biology methods, such as deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) detection, and are performed at or near the point of care. These tests analyze small biological samples on-site rather than sending them to a central laboratory, enabling rapid and accurate identification of pathogens or biomarkers using portable or simplified instruments. By providing quick and reliable results in outpatient, emergency, or remote environments, they support timely treatment decisions and improved health outcomes.

The key product types of near-patient molecular solutions include infectious disease testing kits, urinalysis testing kits, tumor or cancer markers, pregnancy and fertility tests, hematology testing kits, glucose monitoring kits, drugs-of-abuse testing kits, coagulation monitoring kits, cardiometabolic monitoring kits, and others. Infectious disease testing kits are diagnostic tools designed to quickly detect and identify pathogens such as bacteria, viruses, or parasites in patient samples to support prompt diagnosis and treatment. The different technologies used include polymerase chain reaction (PCR)-based methods, genetic sequencing-based methods, and hybridization-based techniques, and they serve various end users such as hospitals and clinics, ambulatory care centers, research laboratories, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The near-patient molecular solutions market research report is one of a series of new reports from The Business Research Company that provides near-patient molecular solutions market statistics, including the near-patient molecular solutions industry global market size, regional shares, competitors with the near-patient molecular solutions market share, detailed near-patient molecular solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the near-patient molecular solutions industry. This near-patient molecular solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The near-patient molecular solutions market size has grown rapidly in recent years. It will grow from $4.13 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period resulted from increasing demand for rapid infectious disease diagnosis, rising prevalence of communicable diseases, growing focus on decentralized healthcare delivery, a surge in point-of-care testing programs within public health systems, expansion of healthcare access in low- and middle-income countries, and rising awareness of early disease detection.

The near-patient molecular solutions market size is expected to see strong growth in the next few years. It will grow to $6.656 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period will be driven by the increasing burden of chronic and emerging infectious diseases, rising adoption of precision and personalized medicine approaches, growing integration of near-patient testing into primary care networks, a surge in government initiatives aimed at strengthening diagnostic infrastructure, expansion of community- and home-based testing models, and rising healthcare expenditure supporting broader diagnostic accessibility. Major trends in the forecast period include technological advancements in microfluidic cartridge design, progress in multiplex molecular assay platforms, innovations in sample-to-answer portable analyzers, developments in connectivity-enabled data reporting systems, research and development in reagent miniaturization for field use, and innovations in fully automated near-patient molecular workflows.

Growing demand for home-based point-of-care devices is anticipated to drive the expansion of the near-patient molecular solutions market in the coming years. These home-based point-of-care devices are diagnostic testing systems operated by patients or non-laboratory users at or near their homes, allowing sample collection, analysis, or result interpretation outside a conventional central laboratory and close to the site of care. The increasing popularity of home-based point-of-care devices is fueled by consumer preference for convenient, rapid, and accessible health monitoring beyond traditional healthcare settings. Near-patient molecular solutions complement these devices by delivering accurate, fast, and portable molecular diagnostics suitable for use outside standard laboratory environments. For example, in February 2023, the US Food & Drug Administration (FDA) reported in its COVID-19 testing update that it had issued one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. As a result, the rising demand for home-based point-of-care devices is contributing to the growth of the near-patient molecular solutions market.

Key players in the near-patient molecular solutions market are focusing on integrating advanced technologies, such as isothermal nucleic acid amplification, to improve testing efficiency, portability, and diagnostic accuracy. Isothermal nucleic acid amplification is a molecular diagnostic technique that amplifies target nucleic acid sequences at a constant temperature, eliminating the need for thermal cycling used in conventional polymerase chain reaction (PCR) methods. This enables rapid, sensitive, and compact molecular testing. For instance, in June 2023, Cue Health Inc., a US-based healthcare technology company specializing in molecular diagnostics, received FDA marketing authorization for the Cue COVID-19 Molecular Test. This isothermal amplification-based diagnostic device is designed for at-home and point-of-care detection of SARS-CoV-2 RNA. The system includes a single-use cartridge, a Bluetooth-enabled reader, and a mobile app that guides users through testing and provides results in approximately 20 minutes. The Cue COVID-19 Molecular Test enhances access to accurate molecular diagnostics, shortens turnaround time, and facilitates real-time health decision-making outside traditional laboratory settings.

In July 2024, Roche Holding AG, a Switzerland-based provider of in-vitro diagnostics and pharmaceuticals, acquired LumiraDx's point-of-care (POC) technology business for $353.5 million. This acquisition gives Roche access to LumiraDx's portable, multi-assay diagnostic platform, strengthening its decentralized and near-patient testing capabilities, expanding its presence in primary care and community settings, and improving the delivery of rapid, reliable diagnostic results outside conventional laboratories. LumiraDx Group Limited, a UK-based provider of next-generation point-of-care diagnostics, is recognized for its compact instrument that integrates immunoassay, clinical chemistry, and emerging molecular testing capabilities for near-patient applications.

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMerieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

North America was the largest region in the near-patient molecular solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in near-patient molecular solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the near-patient molecular solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The near-patient molecular solutions market consists of sales of sample preparation devices, nucleic acid extraction kits, portable molecular analyzers, isothermal amplification kits, microfluidic cartridges, and multiplex detection panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Near-Patient Molecular Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on near-patient molecular solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for near-patient molecular solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The near-patient molecular solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Infectious Diseases Testing Kits; Urinalysis Testing Kits; Tumor Or Cancer Markers; Pregnancy And Fertility; Hematology Testing Kits; Glucose Monitoring Kits; Drugs-Of-Abuse Testing Kits; Coagulation Monitoring Kits; Cardiometabolic Monitoring Kits; Other Product Types
2) By Technology: Polymerase Chain Reaction (PCR)-Based; Genetic Sequencing-Based; Hybridization-Based; Microarray-Based
3) By End-User: Hospitals And Clinics; Ambulatory Care Centers; Research Laboratories; Home Care Settings; Other End-Users
Subsegments:
1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits; Human Immunodeficiency Virus Testing Kits; Influenza Testing Kits; COVID-19 Testing Kits
2) By Urinalysis Testing Kits: Protein Testing Kits; Glucose Testing Kits; Ketone Testing Kits; Nitrite Testing Kits
3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits; Carcinoembryonic Antigen Testing Kits; Cancer Antigen 125 Testing Kits; Alpha-Fetoprotein Testing Kits
4) By Pregnancy And Fertility: Ovulation Testing Kits; Early Pregnancy Testing Kits; Digital Pregnancy Testing Kits; Home Fertility Monitoring Kits
5) By Hematology Testing Kits: Complete Blood Count Testing Kits; Hemoglobin Testing Kits; White Blood Cell Count Testing Kits; Platelet Count Testing Kits
6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits; Continuous Glucose Monitoring Kits; Non-Invasive Glucose Testing Kits; Disposable Glucose Test Strips
7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits; Saliva Drug Testing Kits; Hair Drug Testing Kits; Blood Drug Testing Kits
8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits; International Normalized Ratio Testing Kits; Activated Partial Thromboplastin Time Testing Kits; D-Dimer Testing Kits
9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits; Triglyceride Testing Kits; Low-Density Lipoprotein Testing Kits; High-Density Lipoprotein Testing Kits
10) By Other Product Types: Allergy Testing Kits; Thyroid Function Testing Kits; Vitamin Deficiency Testing Kits; Liver Function Testing Kits
Companies Mentioned: Bosch Healthcare Solutions GmbH; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Hologic Inc.; bioMerieux SA; Sysmex Corporation; QuidelOrtho Corporation; QIAGEN NV; DiaSorin SpA; OraSure Technologies Inc.; Molbio Diagnostics Pvt Ltd; Cue Health Inc.; Biocartis Group NV; Vela Diagnostics Pte Ltd; Co-Diagnostics Inc.; Hyris Ltd; Genedrive plc.
Countries:

Product Code: r40065

1. Executive Summary

2. Near-Patient Molecular Solutions Market Characteristics

3. Near-Patient Molecular Solutions Market Trends And Strategies

4. Near-Patient Molecular Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Near-Patient Molecular Solutions Growth Analysis And Strategic Analysis Framework

5.1. Global Near-Patient Molecular Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Near-Patient Molecular Solutions Market Growth Rate Analysis
5.4. Global Near-Patient Molecular Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Near-Patient Molecular Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Near-Patient Molecular Solutions Total Addressable Market (TAM)

6. Near-Patient Molecular Solutions Market Segmentation

6.1. Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases Testing Kits
Urinalysis Testing Kits
Tumor Or Cancer Markers
Pregnancy And Fertility
Hematology Testing Kits
Glucose Monitoring Kits
Drugs-Of-Abuse Testing Kits
Coagulation Monitoring Kits
Cardiometabolic Monitoring Kits
Other Product Types
6.2. Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)-Based
Genetic Sequencing-Based
Hybridization-Based
Microarray-Based
6.3. Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Care Centres
Research Laboratories
Home Care Settings
Other End-Users
6.4. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatitis Testing Kits
Human Immunodeficiency Virus Testing Kits
Influenza Testing Kits
COVID-19 Testing Kits
6.5. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Testing Kits
Glucose Testing Kits
Ketone Testing Kits
Nitrite Testing Kits
6.6. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostate-Specific Antigen Testing Kits
Carcinoembryonic Antigen Testing Kits
Cancer Antigen 125 Testing Kits
Alpha-Fetoprotein Testing Kits
6.7. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ovulation Testing Kits
Early Pregnancy Testing Kits
Digital Pregnancy Testing Kits
Home Fertility Monitoring Kits
6.8. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Complete Blood Count Testing Kits
Hemoglobin Testing Kits
White Blood Cell Count Testing Kits
Platelet Count Testing Kits
6.9. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Self-Monitoring Blood Glucose Kits
Continuous Glucose Monitoring Kits
Non-Invasive Glucose Testing Kits
Disposable Glucose Test Strips
6.10. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urine Drug Testing Kits
Saliva Drug Testing Kits
Hair Drug Testing Kits
Blood Drug Testing Kits
6.11. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prothrombin Time Testing Kits
International Normalized Ratio Testing Kits
Activated Partial Thromboplastin Time Testing Kits
D-Dimer Testing Kits
6.12. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cholesterol Testing Kits
Triglyceride Testing Kits
Low-Density Lipoprotein Testing Kits
High-Density Lipoprotein Testing Kits
6.13. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergy Testing Kits
Thyroid Function Testing Kits
Vitamin Deficiency Testing Kits
Liver Function Testing Kits

7. Near-Patient Molecular Solutions Market Regional And Country Analysis

7.1. Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Near-Patient Molecular Solutions Market

8.1. Asia-Pacific Near-Patient Molecular Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Near-Patient Molecular Solutions Market

9.1. China Near-Patient Molecular Solutions Market Overview
9.2. China Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Near-Patient Molecular Solutions Market

10.1. India Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Near-Patient Molecular Solutions Market

11.1. Japan Near-Patient Molecular Solutions Market Overview
11.2. Japan Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Near-Patient Molecular Solutions Market

12.1. Australia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Near-Patient Molecular Solutions Market

13.1. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Near-Patient Molecular Solutions Market

14.1. South Korea Near-Patient Molecular Solutions Market Overview
14.2. South Korea Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Near-Patient Molecular Solutions Market

15.1. Western Europe Near-Patient Molecular Solutions Market Overview
15.2. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Near-Patient Molecular Solutions Market

16.1. UK Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Near-Patient Molecular Solutions Market

17.1. Germany Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Near-Patient Molecular Solutions Market

18.1. France Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Near-Patient Molecular Solutions Market

19.1. Italy Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Near-Patient Molecular Solutions Market

20.1. Spain Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Near-Patient Molecular Solutions Market

21.1. Eastern Europe Near-Patient Molecular Solutions Market Overview
21.2. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Near-Patient Molecular Solutions Market

22.1. Russia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Near-Patient Molecular Solutions Market

23.1. North America Near-Patient Molecular Solutions Market Overview
23.2. North America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Near-Patient Molecular Solutions Market

24.1. USA Near-Patient Molecular Solutions Market Overview
24.2. USA Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Near-Patient Molecular Solutions Market

25.1. Canada Near-Patient Molecular Solutions Market Overview
25.2. Canada Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Near-Patient Molecular Solutions Market

26.1. South America Near-Patient Molecular Solutions Market Overview
26.2. South America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Near-Patient Molecular Solutions Market

27.1. Brazil Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Near-Patient Molecular Solutions Market

28.1. Middle East Near-Patient Molecular Solutions Market Overview
28.2. Middle East Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Near-Patient Molecular Solutions Market

29.1. Africa Near-Patient Molecular Solutions Market Overview
29.2. Africa Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Near-Patient Molecular Solutions Market Competitive Landscape And Company Profiles

30.1. Near-Patient Molecular Solutions Market Competitive Landscape
30.2. Near-Patient Molecular Solutions Market Company Profiles
- 30.2.1. Bosch Healthcare Solutions GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Near-Patient Molecular Solutions Market Other Major And Innovative Companies

31.1. Siemens Healthineers AG
31.2. Hologic Inc.
31.3. bioMerieux SA
31.4. Sysmex Corporation
31.5. QuidelOrtho Corporation
31.6. QIAGEN NV
31.7. DiaSorin SpA
31.8. OraSure Technologies Inc.
31.9. Molbio Diagnostics Pvt Ltd
31.10. Cue Health Inc.
31.11. Biocartis Group NV
31.12. Vela Diagnostics Pte Ltd
31.13. Co-Diagnostics Inc.
31.14. Hyris Ltd
31.15. Genedrive plc

32. Global Near-Patient Molecular Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Near-Patient Molecular Solutions Market

34. Recent Developments In The Near-Patient Molecular Solutions Market

35. Near-Patient Molecular Solutions Market High Potential Countries, Segments and Strategies

35.1 Near-Patient Molecular Solutions Market In 2029 - Countries Offering Most New Opportunities
35.2 Near-Patient Molecular Solutions Market In 2029 - Segments Offering Most New Opportunities
35.3 Near-Patient Molecular Solutions Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer